Kristen Kluska's Stock Ratings

Cantor Fitzgerald Analyst

Kristen Kluska is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/03/2024

Overall Average Return

48.4%

Smart Score

81.2%

Overall Average Return Percentile

93rd

Number of Ratings

217
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Analyst Expectations For Sarepta Therapeutics's Future
Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings)
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts
Decoding 12 Analyst Evaluations For Capricor Therapeutics
A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics
The Analyst Verdict: Amicus Therapeutics In The Eyes Of 8 Experts
Amicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
Peeling Back The Layers: Exploring Amicus Therapeutics Through Analyst Insights
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved